Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medx Health Corp V.MDX

Alternate Symbol(s):  MDXHF

MedX Health Corp. is a medical device and software company. It develops and manufactures skin-related screening tools and phototherapy devices for pain relief and tissue repair. It focuses on skin health with its SIAscopy on DermSecure telemedicine platform, utilizing its SIAscopy technology. SIAscopy is a medical device technology that is used to scan skin for suspicious moles and lesions and, including DermSecure, its telemedicine software application, and phototherapeutic medical devices, which use light energy in lower-level laser and light-emitting diode to provide treatment of pain and tissue damage in the rehabilitation market. Its products SIAMETRICS, SIMSYS, and MoleMate include hand-held devices that use patented technology utilizing light and its remittance to view up to two millimeters beneath suspicious moles and lesions in a pain free, non-invasive manner. Its SIAscopy on DermSecure telemedicine platform enables the Web-based operation of its SIAscopy scanning technology.


TSXV:MDX - Post by User

Comment by Insightful1on Jul 04, 2021 9:49am
159 Views
Post# 33490550

RE:RE:RE:RE:RE:Disappointment Continues

RE:RE:RE:RE:RE:Disappointment ContinuesI think MedX is executing on their strategy that I laid out on my earlier post.

I think DermTech shares traded from Aug,2017- Dec 2020 from $19.40-$11.49 loosing lots of money. Then they announced their platform with a few clinical papers and their shares took off. Last quarter they lost $15.1 million so I think your statements earning investors money are a bit misguided.If you are referring to share price appreciation as always it depends on when you invested.
Mexico is a fair point however I would suggest COVID is very real and it is slowing down a normally slow regulatory proceedues. MedX is in 35 countries I am sure they know how to get through the regulatory process in Mexico. MedX does communicate to investors, you seem to be the only poster who cannot get through to their IR company. 

Here is the contact site; https://www.venturenorthcapital.com/
<< Previous
Bullboard Posts
Next >>